Delivery Order SPE2DE21D0007-SPE2D623F0TEH
Award Date 9/7/23
Potential Completion Date 9/12/23
Potential Value $169
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics Inc. has been awarded a $338 delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide 4562132256 ANTI-E BIOCLONE 1X5ML. The fixed-price with economic price adjustment contract has a period of performance through September 13, 2023. No set-aside provisions were applied to this award. The place of performance will be Raritan, NJ. The Defense Logistics Agency Troop Support Medical supports the...
- Ortho-Clinical Diagnostics Inc. was awarded a $507 fixed-price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical on August 23, 2023. The order is for the delivery of ANTI-E BIOCLONE 1X5ML to a place of performance in Raritan, New Jersey, with a period of performance completion date of August 28, 2023. No set-aside designation was applied to this award. As the Defense Logistics Agency Troop Support Medical supports...
- Ortho-Clinical Diagnostics Inc. has been awarded a delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The fixed price with economic price adjustment contract has a potential value of $169 and calls for the delivery of 4561863805 ANTI-E BIOCLONE 1X5ML medical supplies. Performance will occur in Raritan, New Jersey by September 7, 2023. No set-aside provisions were applied to this award to supply the Defense Logistics...
- Ortho-Clinical Diagnostics Inc. was awarded a delivery order against an unspecified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The fixed price with economic price adjustment contract has a potential value of $169 and requires the delivery of 4561974861 ANTI-E BIOCLONE 1X5ML to a place of performance in Raritan, New Jersey by August 31, 2023. No set-aside provisions were applied to this award to supply medical products in support of the Defense...
- Ortho-Clinical Diagnostics Inc. was awarded a $916.27 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Troop Support Medical (DLA) to provide ANTI-A BIOCLONE 15X10ML from its place of performance in Raritan, New Jersey. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity medical product contracts and has a period of performance from July 7 to July 28, 2023. As the prime contractor, Ortho-Clinical Diagnostics will fulfill...
- Ortho-Clinical Diagnostics Inc. has been awarded a $169,280 fixed-price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract. The order is for 4561436224 units of ANTI-E BIOCLONE 1X5ML reagents to be delivered from Ortho-Clinical's facility in Raritan, New Jersey to an unspecified location by July 12, 2023. No set-aside designation or subcontractors are indicated. The Defense Logistics Agency Troop Support Medical supports the...
- Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical. The delivery order, issued on August 7, 2023, is for the procurement of 4561733234 ANTI-A BIOCLONE 15X10ML, with a period of performance concluding on August 28, 2023. No set-aside provisions were applied to this award. Place of performance will be in Raritan, New Jersey. As...
- Ortho-Clinical Diagnostics Inc. was awarded a $916 fixed-price delivery order with economic price adjustment against an unidentified government-wide acquisition contract vehicle. The contract calls for the delivery of 15 boxes containing 10 milliliters each of ANTI-B BIOCLONE to the Defense Logistics Agency Troop Support Medical facility in Raritan, New Jersey, with all work to be completed by August 11, 2023. No set-aside provisions were applied to this award to supply medical products in...
- Ortho-Clinical Diagnostics Inc. was awarded a $5,543.20 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4561371436 units of ANTI-A BIOCLONE 15X10ML. The place of performance will be in Raritan, New Jersey, with work scheduled to be completed by July 3, 2023 under a start date of June 28, 2023. As a component of the Department of Defense, DLA supports America's armed forces by procuring and providing logistics...
- Ortho-Clinical Diagnostics Inc. was awarded a $4,581 fixed price delivery order against an unidentified government-wide acquisition contract by the Defense Logistics Agency Troop Support Medical to provide 15 boxes containing 10 milliliters each of anti-B bioclones. Place of performance will be the prime contractor's facility located in Raritan, New Jersey. The delivery order has a period of performance from July 20, 2023 through July 25, 2023 and utilizes fixed pricing with economic price...
- SPE2DE21D0007Indefinite Delivery Contract
- SPE2DE21D0007-SPE2D623F0TEHDelivery Order
Ortho-Clinical Diagnostics Inc. was awarded a $169 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Troop Support Medical to provide ANTI-E BIOCLONE 1X5ML. The place of performance is Raritan, NJ 08869. No set-aside designation was used for this award. The delivery order was issued against an existing DLA Troop Support Medical contract vehicle to supply medical products and services in support of the agency's mission. Performance is required no later than September 12, 2023.
Generated 1/2/24, 1:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $169 | 9/7/23 |